Pay in 4 interest-free payments of $5.89 Learn more
Ships within 48 hours · Estimated delivery Aug 21 - Aug 26
GLP-1 Drugs and Kidney Stones: Do They Raise Risk
Idorn T, Knop FK, Jrgensen M, Jensen T, Resuli M, Hansen PM et al (2013) Safety and efficacy of liraglutide in patients with type 2 diabetes and end-stage renal disease: protocol for an investigator-initiated prospective, randomised, placebo-controlled, double-blinded, parallel intervention study
The first-round optimization led to Compound 70 , which contains a 5-methyl-1-phenyl benzimidazole moiety and exhibited an excellent increase in potency (IC 50 : 52 nM)
In a phase II trial, the combination of cagrilintide and semaglutide (known as CagriSema) demonstrated an average weight loss of 15.6% after 32 weeks of treatment
As the research grows, one thing is clear: GLP-1 medications are changing the way we think about chronic disease and metabolic health
In the context of trichology (the study of hair and scalp), peptides exhibit several beneficial mechanisms: Stimulation of dermal papilla cells , critical regulators of the hair growth cycle Upregulation of vascular endothelial growth factor (VEGF) to improve microcirculation and nutrient delivery Reduction of pro-inflammatory cytokines , which compromise follicular integrity Support of extracellular matrix (ECM) remodelling , vital for hair shaft anchoring and follicle health By targeting these pathways, peptides hair growth interventions present a multifactorial strategy for combating hair loss and promoting sustained follicular regeneration
